4.16.2020 TDOC Bearish Divergence up to the Monthly TF

Mis à jour
COVID has pumped this stock to overbought.
Teladoc Health now anticipates revenues for the first quarter of 2020 to be in the range of $180-181 million, up 40% year over year. Adjusted EBITDA is expected in the band of $10-11 million compared with $1.2 million in the first quarter of 2019.

-NFA
Note
4.17.2020 Short
Technical IndicatorsTDOCTrend Analysis

Clause de non-responsabilité